Logo image of BC

BRUNSWICK CORP (BC) Stock Fundamental Analysis

USA - NYSE:BC - US1170431092 - Common Stock

64.21 USD
-1.86 (-2.82%)
Last: 11/4/2025, 8:04:00 PM
64.21 USD
0 (0%)
After Hours: 11/4/2025, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BC. BC was compared to 33 industry peers in the Leisure Products industry. BC has a medium profitability rating, but doesn't score so well on its financial health evaluation. BC is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BC had positive earnings in the past year.
BC had a positive operating cash flow in the past year.
In the past 5 years BC has always been profitable.
BC had a positive operating cash flow in each of the past 5 years.
BC Yearly Net Income VS EBIT VS OCF VS FCFBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

With a Return On Assets value of -4.41%, BC perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
The Return On Equity of BC (-14.60%) is comparable to the rest of the industry.
BC's Return On Invested Capital of 4.96% is fine compared to the rest of the industry. BC outperforms 69.70% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BC is above the industry average of 7.27%.
The 3 year average ROIC (11.29%) for BC is well above the current ROIC(4.96%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -4.41%
ROE -14.6%
ROIC 4.96%
ROA(3y)6.58%
ROA(5y)8.11%
ROE(3y)20.05%
ROE(5y)23.17%
ROIC(3y)11.29%
ROIC(5y)12.56%
BC Yearly ROA, ROE, ROICBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

In the last couple of years the Profit Margin of BC has declined.
With a decent Operating Margin value of 5.65%, BC is doing good in the industry, outperforming 69.70% of the companies in the same industry.
In the last couple of years the Operating Margin of BC has declined.
BC's Gross Margin of 24.65% is on the low side compared to the rest of the industry. BC is outperformed by 60.61% of its industry peers.
BC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.65%
PM (TTM) N/A
GM 24.65%
OM growth 3Y-15.92%
OM growth 5Y-7.05%
PM growth 3Y-37.44%
PM growth 5YN/A
GM growth 3Y-2.7%
GM growth 5Y-0.86%
BC Yearly Profit, Operating, Gross MarginsBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

BC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BC has been reduced compared to 1 year ago.
The number of shares outstanding for BC has been reduced compared to 5 years ago.
The debt/assets ratio for BC is higher compared to a year ago.
BC Yearly Shares OutstandingBC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BC Yearly Total Debt VS Total AssetsBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

The Debt to FCF ratio of BC is 3.72, which is a good value as it means it would take BC, 3.72 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.72, BC is doing good in the industry, outperforming 69.70% of the companies in the same industry.
BC has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
BC has a worse Debt to Equity ratio (1.28) than 78.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 3.72
Altman-Z N/A
ROIC/WACC0.47
WACC10.51%
BC Yearly LT Debt VS Equity VS FCFBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

BC has a Current Ratio of 1.78. This is a normal value and indicates that BC is financially healthy and should not expect problems in meeting its short term obligations.
BC's Current ratio of 1.78 is on the low side compared to the rest of the industry. BC is outperformed by 63.64% of its industry peers.
BC has a Quick Ratio of 1.78. This is a bad value and indicates that BC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.73, BC is not doing good in the industry: 75.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.73
BC Yearly Current Assets VS Current LiabilitesBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

4

3. Growth

3.1 Past

BC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.22%.
The Earnings Per Share has been growing slightly by 1.13% on average over the past years.
BC shows a decrease in Revenue. In the last year, the revenue decreased by -4.78%.
The Revenue has been growing slightly by 4.97% on average over the past years.
EPS 1Y (TTM)-49.22%
EPS 3Y-18%
EPS 5Y1.13%
EPS Q2Q%-17.09%
Revenue 1Y (TTM)-4.78%
Revenue growth 3Y-3.6%
Revenue growth 5Y4.97%
Sales Q2Q%6.82%

3.2 Future

The Earnings Per Share is expected to grow by 20.12% on average over the next years. This is a very strong growth
Based on estimates for the next years, BC will show a small growth in Revenue. The Revenue will grow by 3.75% on average per year.
EPS Next Y-27.05%
EPS Next 2Y-2.53%
EPS Next 3Y8.13%
EPS Next 5Y20.12%
Revenue Next Year0.42%
Revenue Next 2Y2.51%
Revenue Next 3Y3.55%
Revenue Next 5Y3.75%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BC Yearly Revenue VS EstimatesBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
BC Yearly EPS VS EstimatesBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

BC is valuated rather expensively with a Price/Earnings ratio of 21.91.
Compared to the rest of the industry, the Price/Earnings ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 69.70% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.03, BC is valued at the same level.
A Price/Forward Earnings ratio of 14.82 indicates a correct valuation of BC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 78.79% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.27, BC is valued a bit cheaper.
Industry RankSector Rank
PE 21.91
Fwd PE 14.82
BC Price Earnings VS Forward Price EarningsBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BC indicates a somewhat cheap valuation: BC is cheaper than 66.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BC is valued cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.12
EV/EBITDA 10.59
BC Per share dataBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)19.32
EPS Next 2Y-2.53%
EPS Next 3Y8.13%

6

5. Dividend

5.1 Amount

BC has a Yearly Dividend Yield of 2.56%. Purely for dividend investing, there may be better candidates out there.
BC's Dividend Yield is a higher than the industry average which is at 4.02.
Compared to an average S&P500 Dividend Yield of 2.38, BC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.56%

5.2 History

On average, the dividend of BC grows each year by 13.66%, which is quite nice.
BC has paid a dividend for at least 10 years, which is a reliable track record.
BC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.66%
Div Incr Years12
Div Non Decr Years16
BC Yearly Dividends per shareBC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
BC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-47.09%
EPS Next 2Y-2.53%
EPS Next 3Y8.13%
BC Yearly Income VS Free CF VS DividendBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

BRUNSWICK CORP

NYSE:BC (11/4/2025, 8:04:00 PM)

After market: 64.21 0 (0%)

64.21

-1.86 (-2.82%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)10-23 2025-10-23/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners108.48%
Inst Owner Change-0.14%
Ins Owners0.92%
Ins Owner Change0.18%
Market Cap4.19B
Revenue(TTM)5.18B
Net Income(TTM)-238500000
Analysts75.38
Price Target74.98 (16.77%)
Short Float %7.87%
Short Ratio6.64
Dividend
Industry RankSector Rank
Dividend Yield 2.56%
Yearly Dividend1.67
Dividend Growth(5Y)13.66%
DP-47.09%
Div Incr Years12
Div Non Decr Years16
Ex-Date11-26 2025-11-26 (0.43)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.81%
Min EPS beat(2)10.64%
Max EPS beat(2)18.98%
EPS beat(4)4
Avg EPS beat(4)44.16%
Min EPS beat(4)10.1%
Max EPS beat(4)136.9%
EPS beat(8)4
Avg EPS beat(8)18.17%
EPS beat(12)5
Avg EPS beat(12)11.62%
EPS beat(16)8
Avg EPS beat(16)9.25%
Revenue beat(2)2
Avg Revenue beat(2)8.79%
Min Revenue beat(2)4.71%
Max Revenue beat(2)12.87%
Revenue beat(4)4
Avg Revenue beat(4)7.27%
Min Revenue beat(4)4.71%
Max Revenue beat(4)12.87%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)4
Avg Revenue beat(12)-1.51%
Revenue beat(16)6
Avg Revenue beat(16)-1.59%
PT rev (1m)8.86%
PT rev (3m)24.4%
EPS NQ rev (1m)-9.54%
EPS NQ rev (3m)19.25%
EPS NY rev (1m)0.15%
EPS NY rev (3m)1.61%
Revenue NQ rev (1m)-1.96%
Revenue NQ rev (3m)-3.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.88%
Valuation
Industry RankSector Rank
PE 21.91
Fwd PE 14.82
P/S 0.81
P/FCF 7.12
P/OCF 5.7
P/B 2.57
P/tB 47.72
EV/EBITDA 10.59
EPS(TTM)2.93
EY4.56%
EPS(NY)4.33
Fwd EY6.75%
FCF(TTM)9.01
FCFY14.04%
OCF(TTM)11.26
OCFY17.54%
SpS79.35
BVpS25.01
TBVpS1.35
PEG (NY)N/A
PEG (5Y)19.32
Graham Number40.61
Profitability
Industry RankSector Rank
ROA -4.41%
ROE -14.6%
ROCE 6.97%
ROIC 4.96%
ROICexc 5.34%
ROICexgc 8.84%
OM 5.65%
PM (TTM) N/A
GM 24.65%
FCFM 11.36%
ROA(3y)6.58%
ROA(5y)8.11%
ROE(3y)20.05%
ROE(5y)23.17%
ROIC(3y)11.29%
ROIC(5y)12.56%
ROICexc(3y)12.61%
ROICexc(5y)14.42%
ROICexgc(3y)24.11%
ROICexgc(5y)28.09%
ROCE(3y)15.87%
ROCE(5y)17.66%
ROICexgc growth 3Y-26.29%
ROICexgc growth 5Y-12.51%
ROICexc growth 3Y-22.36%
ROICexc growth 5Y-13.21%
OM growth 3Y-15.92%
OM growth 5Y-7.05%
PM growth 3Y-37.44%
PM growth 5YN/A
GM growth 3Y-2.7%
GM growth 5Y-0.86%
F-Score5
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 3.72
Debt/EBITDA 3.58
Cap/Depr 49.98%
Cap/Sales 2.83%
Interest Coverage 250
Cash Conversion 125.44%
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 0.73
Altman-Z N/A
F-Score5
WACC10.51%
ROIC/WACC0.47
Cap/Depr(3y)110.64%
Cap/Depr(5y)120.16%
Cap/Sales(3y)4.47%
Cap/Sales(5y)4.44%
Profit Quality(3y)112.61%
Profit Quality(5y)110.96%
High Growth Momentum
Growth
EPS 1Y (TTM)-49.22%
EPS 3Y-18%
EPS 5Y1.13%
EPS Q2Q%-17.09%
EPS Next Y-27.05%
EPS Next 2Y-2.53%
EPS Next 3Y8.13%
EPS Next 5Y20.12%
Revenue 1Y (TTM)-4.78%
Revenue growth 3Y-3.6%
Revenue growth 5Y4.97%
Sales Q2Q%6.82%
Revenue Next Year0.42%
Revenue Next 2Y2.51%
Revenue Next 3Y3.55%
Revenue Next 5Y3.75%
EBIT growth 1Y-44.16%
EBIT growth 3Y-18.95%
EBIT growth 5Y-2.43%
EBIT Next Year27.55%
EBIT Next 3Y18.74%
EBIT Next 5Y18.04%
FCF growth 1Y46.14%
FCF growth 3Y-4.9%
FCF growth 5Y5.54%
OCF growth 1Y1.46%
OCF growth 3Y-9.08%
OCF growth 5Y-0.13%

BRUNSWICK CORP / BC FAQ

What is the fundamental rating for BC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BC.


What is the valuation status for BC stock?

ChartMill assigns a valuation rating of 4 / 10 to BRUNSWICK CORP (BC). This can be considered as Fairly Valued.


How profitable is BRUNSWICK CORP (BC) stock?

BRUNSWICK CORP (BC) has a profitability rating of 5 / 10.


What is the financial health of BRUNSWICK CORP (BC) stock?

The financial health rating of BRUNSWICK CORP (BC) is 3 / 10.


Can you provide the dividend sustainability for BC stock?

The dividend rating of BRUNSWICK CORP (BC) is 6 / 10 and the dividend payout ratio is -47.09%.